Professional
Added to YB: 2026-05-22
Pitch date: 2026-05-20
SDGR [neutral]
Schrödinger, Inc.
+8%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.
Market Cap
$920.6M
Pitch Price
$12.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.46
P/E
-8.75
EV/Sales
2.47
Sector
Health Care Technology
Category
growth
Pernas Research More Research Needed On: Schrödinger, Inc.
SDGR (more research needed): Leading physics-based computational chemistry platform for drug discovery, ~70% rev from pharma software. Deep TAM penetration w/ top pharmas, software growth slowing to ~10%. Biotech discovery arm has co-developed assets but repeatability uncertain. AI risk: physics-based approach may become validation layer or lose moat to AI-native systems. Evaluating AI integration.
Read full article (1 min)